New clinical trials in Peru: 76 since Nov 2024

Name: New clinical trials in Peru
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New clinical trials with a site in Peru: 76 rows for $5, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 2 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/peru, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated October 5, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

76 clinical studies with a site in Peru were first posted on ClinicalTrials.gov from November 12, 2024 to October 5, 2026; 40 have an industry sponsor and 54 are recruiting or about to. The newest, NCT07858968, was posted on October 5, 2026: Pelvic Floor Rehabilitation Programme for Women With Urinary Incontinence in a Peruvian Public Hospital (Hospital Nacional Edgardo Rebagliati Martins).

The request: Every new clinical trial with a site in Peru, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

76New trials
40Industry sponsored
54Recruiting or not yet
October 5, 2026Latest posted

Newest trials

The newest 76 of 76, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
October 5, 2026	NCT07858968	Pelvic Floor Rehabilitation Programme for Women With Urinary Incontinence in a Peruvian Public Hospital	Hospital Nacional Edgardo Rebagliati Martins	Not applicable	Active not recruiting	Urinary Incontinence, Urinary Incontinence, Stress, Urinary Incontinence, Urge, Mixed Urinary Incontinence	89	Peru	clinicaltrials.gov
October 1, 2026	NCT07851025	Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced...	AstraZeneca	Phase 3	Recruiting	Epithelial Ovarian Cancer	950	Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Colombia...	clinicaltrials.gov
September 14, 2026	NCT07818824	A Clinical Study of the HCMV-TB Vaccine Candidate VIR-1778 in Healthy Adults	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	Not yet recruiting	Tuberculosis	116	Peru	clinicaltrials.gov
September 10, 2026	NCT07813286	Gamified Web-Based Mindfulness for University Student Stress	Universidad Peruana Cayetano Heredia	Not applicable	Completed	Stress	20	Peru	clinicaltrials.gov
August 10, 2026	NCT07753993	A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.	AstraZeneca	Phase 3	Recruiting	Chronic Kidney Disease	7,000	Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark...	clinicaltrials.gov
August 4, 2026	NCT07744477	Validation of Serum Metabolite Differences in Patients With Gallstones and Gallbladder Cancer	Centre Paul Strauss	Observational	Completed	Gallstone Disease, Gallbladder Malignant Neoplasm	230	Bolivia, Chile, Germany, Peru	clinicaltrials.gov
June 25, 2026	NCT07667738	Evaluating the Effectiveness of the Common Elements Treatment Approach (CETA) in Peru: Mechanisms of Individual and Intergenerational Change	University of Notre Dame	Phase 2	Recruiting	Violence, Parenting, Poverty, Depression, Mental Health, Posttraumatic Stress, Economic Factors, Child Psychology	600	Peru	clinicaltrials.gov
June 22, 2026	NCT07658976	Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy	HIV Prevention Trials Network	Phase 3	Not yet recruiting	HIV Infection, Sexually Transmitted Infection	400	Argentina, Brazil, Peru, United States	clinicaltrials.gov
June 18, 2026	NCT07656012	Re-evaluating the Duration in Children of TB Treatment	University of Wisconsin, Madison	Phase 2	Not yet recruiting	Tuberculosis	230	Peru	clinicaltrials.gov
June 15, 2026	NCT07647419	Effect of Aromatherapy and Music Therapy on Physiological Response and Pain During Mandibular Third Molar Extraction	Universidad Científica del Sur	Not applicable	Completed	Dental Anxiety, Third Molar Extraction Surgery	102	Peru	clinicaltrials.gov
June 11, 2026	NCT07643597	Volume Removal Intolerance During Net Ultrafiltration in Acute Kidney Injury Patients	Hospital Las Higueras	Observational	Recruiting	Acute Kidney Injury, Fluid Overload, Fluid Overload in Dialysis Patients, Critical Illness, Renal Replacement Therapy...	128	Brazil, Chile, Colombia, Ecuador, Italy, Mexico, Peru	clinicaltrials.gov
June 11, 2026	NCT07642817	Validation of Differential Serum Levels for Five Minerals in South American Gallstone Patients With and Without Gallbladder Cancer	Centre Paul Strauss	Observational	Completed	Gallbladder Malignant Neoplasm	230	Bolivia, Chile, Germany, Peru	clinicaltrials.gov
June 9, 2026	NCT07635745	Validation of the Association Between the Abundance of Three Bacterial Genera in Stool Samples and the Risk of Gallbladder Cancer in South...	Centre Paul Strauss	Observational	Completed	Gallbladder Malignant Neoplasm	120	Bolivia, Chile, Germany, Peru	clinicaltrials.gov
June 5, 2026	NCT07630714	A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years...	AstraZeneca	Phase 2	Recruiting	Systemic Lupus Erythematosus	24	Australia, Belgium, Chile, Israel, Japan, Netherlands, Peru, Philippines...	clinicaltrials.gov
June 3, 2026	NCT07624305	A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)	AstraZeneca	Phase 3	Recruiting	Renal Insufficiency, Chronic	2,800	Argentina, Austria, Brazil, Bulgaria, Canada, China, France, Germany, Greece...	clinicaltrials.gov
May 28, 2026	NCT07612332	Non-Immersive Virtual Reality for Gait and Balance Training in Children With Cerebral Palsy	Universidad Nacional de San Agustin de Arequipa	Not applicable	Not yet recruiting	Cerebral Palsy (CP)	10	Peru	clinicaltrials.gov
May 19, 2026	NCT07595042	A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2	Not yet recruiting	Tuberculosis	900	Argentina, Australia, Botswana, Brazil, Haiti, India, Kenya, Malawi, Mexico...	clinicaltrials.gov
May 6, 2026	NCT07569029	A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical...	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	Recruiting	HIV	42	Argentina, Peru, United States, Zimbabwe	clinicaltrials.gov
April 24, 2026	NCT07549776	Ultrasound-guided Versus Landmark-based Spinal Anesthesia in Obese Parturients Undergoing Cesarean Section	Instituto Nacional Materno Perinatal, Peru	Not applicable	Completed	Obesity, Cesarean Section	100	Peru	clinicaltrials.gov
April 21, 2026	NCT07543458	Therapeutics for Moderate and Severe Dengue	Oxford University Clinical Research Unit, Vietnam	Phase 3	Not yet recruiting	Dengue, Severe Dengue, Mosquito-Borne Diseases, Vector Borne Diseases, Arbovirus Infections, Flavivirus Infections, RNA...	8,800	Bangladesh, Brazil, Colombia, Indonesia, Malaysia, Nepal, Peru, Philippines...	clinicaltrials.gov
March 17, 2026	NCT07477041	Promotion of Breast Milk Donation in Breastfeeding Mothers Through a Mobile Health Intervention Using Amamantapp	National University of San Marcos, Peru	Not applicable	Completed	Health Knowledge Attitudes and Practice, Breast Feeding	112	Peru	clinicaltrials.gov
March 2, 2026	NCT07441408	Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis	Bristol-Myers Squibb	Phase 3	Not yet recruiting	Pulmonary Fibrosis	2,380	Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark...	clinicaltrials.gov
February 24, 2026	NCT07430592	This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the...	R. Kiplin Guy	Phase 2	Not yet recruiting	Malaria, Malaria Vivax, Radical Cure	104	Peru	clinicaltrials.gov
February 5, 2026	NCT07390955	A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	Recruiting	HIV	83	Peru, United States, Zimbabwe	clinicaltrials.gov
January 23, 2026	NCT07363590	A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)	Merck Sharp & Dohme LLC	Phase 1	Recruiting	Systemic Lupus Erythematosus, Rheumatoid Arthritis	21	Australia, Belgium, China, Colombia, Georgia, Italy, Japan, Moldova, Peru...	clinicaltrials.gov
January 23, 2026	NCT07361510	A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung...	Bristol-Myers Squibb	Phase 3	Recruiting	Non-Small Cell Lung Cancer (NSCLC)	750	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
January 6, 2026	NCT07318558	A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)	Merck Sharp & Dohme LLC	Phase 3	Recruiting	Ovarian Neoplasms, Ovarian Cancer	900	Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia...	clinicaltrials.gov
December 16, 2025	NCT07284459	Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis	Contineum Therapeutics	Phase 2	Recruiting	Idiopathic Pulmonary Fibrosis	324	Argentina, Australia, Belgium, Canada, Chile, Denmark, France, Germany, Greece...	clinicaltrials.gov
December 3, 2025	NCT07262320	Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America	University of Alabama at Birmingham	Observational	Recruiting	Dialysis, Critically Ill Acute Kidney Injury, Renal Replacement Therapy for Acute Kidney Injury in ICU, Acute Kidney...	1,000	Bolivia, Brazil, Chile, Colombia, Dominican Republic, Ecuador, Guatemala...	clinicaltrials.gov
October 28, 2025	NCT07221734	Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated...	mAbxience Research S.L.	Phase 3	Recruiting	Advanced (Unresectable or Metastatic) Melanoma	632	Bosnia and Herzegovina, Brazil, Chile, Georgia, Greece, Italy, Peru, Portugal...	clinicaltrials.gov
October 7, 2025	NCT07209761	A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 3	Recruiting	Rifampicin-Resistant Pulmonary Tuberculosis, Multidrug-Resistant Pulmonary Tuberculosis	532	China, Georgia, India, Indonesia, Japan, Moldova, Peru, Philippines, South...	clinicaltrials.gov
September 26, 2025	NCT07193771	Altitude and Outcomes in Pediatric ARDS: A Multicenter Study	Latin American Pediatric Collaborative Network	Observational	Recruiting	Respiratory Distress Syndrome, Pediatric, Altitude Hypoxia, High Altitude Effects	1,600	Bolivia, Chile, Colombia, Peru, Uruguay	clinicaltrials.gov
September 25, 2025	NCT07192991	Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America	Latin American Cooperative Oncology Group	Observational	Recruiting	Neuroendocrine Carcinomas, Lung Neuroendocrine Carcinoma	200	Argentina, Brazil, Mexico, Peru	clinicaltrials.gov
September 24, 2025	NCT07190248	A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)	Merck Sharp & Dohme LLC	Phase 3	Recruiting	Non-small Cell Lung Cancer	675	Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia...	clinicaltrials.gov
September 10, 2025	NCT07165496	Text Messaging to Promote HIV Testing in Gay Men	Universidad Peruana Cayetano Heredia	Not applicable	Completed	HIV Testing	400	Peru	clinicaltrials.gov
August 17, 2025	NCT07128199	A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor...	Taiho Oncology, Inc.	Phase 3	Recruiting	Lung Cancer, Adjuvant, Post-surgical, EGFR, Exon 20, Early Stage Lung Cancer, Uncommon EGFR Mutations, NSCLC, Early...	360	Argentina, Australia, Belgium, Brazil, Canada, France, Germany, Greece, Hong...	clinicaltrials.gov
July 28, 2025	NCT07088926	A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis...	AstraZeneca	Phase 2	Recruiting	Bronchiectasis With Pseudomonas Aeruginosa Colonization	435	Argentina, Australia, Belgium, Brazil, Canada, Chile, Denmark, France, Germany...	clinicaltrials.gov
July 24, 2025	NCT07082738	A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease	AstraZeneca	Phase 2	Recruiting	Chronic Obstructive Pulmonary Disease (COPD)	987	Argentina, Australia, Bulgaria, Canada, Chile, China, Denmark, Germany, Greece...	clinicaltrials.gov
July 20, 2025	NCT07074899	Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru	Fred Hutchinson Cancer Center	Not applicable	Completed	HIV/AIDS, Mobile Health, Feasibility Studies, Qualitative Research, Implementation Science, Social Determinants of...	161	Peru	clinicaltrials.gov
July 16, 2025	NCT07069400	An International Observational Study of Adults With Acute Infection	University of Minnesota	Observational	Recruiting	Infectious Disease	1,500	Argentina, Australia, Brazil, Côte d’Ivoire, Denmark, France, Germany, Greece...	clinicaltrials.gov
July 11, 2025	NCT07060807	A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)	Merck Sharp & Dohme LLC	Phase 3	Recruiting	Breast Neoplasms	1,000	Argentina, Australia, Brazil, Canada, Chile, China, Colombia, France, Germany...	clinicaltrials.gov
July 8, 2025	NCT07053839	Effect of a Daily Text Reminder on Asthma Medication Use, Symptom Control, and Lung Function in Children	ROXANA AZNARAN TORRES	Not applicable	Completed	Asthma in Children	64	Peru	clinicaltrials.gov
July 8, 2025	NCT07053514	Same-Day Antiretroviral Therapy as a Behavioral Design Intervention to Reduce Stigma in Key Affected Populations	Yale University	Not applicable	Not yet recruiting	Hiv	139	Peru	clinicaltrials.gov
June 29, 2025	NCT07044297	A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)	Merck Sharp & Dohme LLC	Phase 3	Active not recruiting	Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis	4,390	Argentina, Brazil, Chile, Colombia, Dominican Republic, France, Guatemala...	clinicaltrials.gov
June 29, 2025	NCT07044128	Validate the Efficacy and the Safety of the Keikku Electronic Stethoscope for Its Indication and Intended Purpose, Under the Intended...	Lapsi Health Holding B.V.	Observational	Recruiting	Heart Murmurs, Wheezing	149	Peru	clinicaltrials.gov
June 24, 2025	NCT07032662	Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)	Immunovant Sciences GmbH	Phase 2	Recruiting	Chronic Inflammatory Demyelinating Polyneuropathy	162	Argentina, Australia, Austria, Belgium, Bosnia and Herzegovina, Brazil...	clinicaltrials.gov
June 5, 2025	NCT07006584	Gait Reeducation Program in Older Adults	Universidad Europea de Madrid	Not applicable	Completed	Older Adults (65 Years and Older), Balance, Gait Disorders, Physical Performance, Calf Muscle Weakness, Abdominal...	47	Peru	clinicaltrials.gov
June 2, 2025	NCT07000357	A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event	AstraZeneca	Phase 3	Recruiting	Cardiovascular Disease	15,100	Argentina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czechia, Denmark...	clinicaltrials.gov
May 30, 2025	NCT06996782	A Platform Study in Non-Small Cell Lung Cancer (NSCLC)	AstraZeneca	Phase 1/2	Recruiting	Advanced or Metastatic Non-small Cell Lung Cancer	152	Belgium, Brazil, China, France, Georgia, Germany, Italy, Japan, Malaysia...	clinicaltrials.gov
May 25, 2025	NCT06989502	Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries	Universidad Peruana Cayetano Heredia	Not applicable	Not yet recruiting	Hypertension, Diabetes Mellitus, Neglected Tropical Diseases	2,094	Mozambique, Nepal, Peru	clinicaltrials.gov
May 23, 2025	NCT06987318	A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic...	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	Not yet recruiting	HIV-1-infection	40	Brazil, Peru, United States	clinicaltrials.gov
May 20, 2025	NCT06979596	A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)	Merck Sharp & Dohme LLC	Phase 2	Recruiting	Malignant Neoplasm	250	Argentina, Brazil, Canada, Chile, Malaysia, Peru, Singapore, Spain, Taiwan...	clinicaltrials.gov
May 20, 2025	NCT06979531	Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity	Immunovant Sciences GmbH	Phase 2	Active not recruiting	Primary Sjögren's Syndrome	180	Argentina, Canada, Chile, Germany, Greece, Hungary, Italy, Peru, Poland...	clinicaltrials.gov
May 13, 2025	NCT06966700	A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)	Merck Sharp & Dohme LLC	Phase 3	Recruiting	Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms	2,400	Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Czechia...	clinicaltrials.gov
May 1, 2025	NCT06952803	A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA...	AstraZeneca	Phase 3	Recruiting	Prostate Cancer	700	Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Finland...	clinicaltrials.gov
May 1, 2025	NCT06952504	A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in...	Merck Sharp & Dohme LLC	Phase 3	Recruiting	Endometrial Cancer	1,123	Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia...	clinicaltrials.gov
April 29, 2025	NCT06948110	Deciphering the Genetic Architecture of Autoimmune Diseases	National Human Genome Research Institute (NHGRI)	Observational	Recruiting	Autoimmune Diseases	300	Peru, United States	clinicaltrials.gov
April 18, 2025	NCT06934135	Near-infrared Transcranial Laser Therapy in Subjects With Major Depressive Disorder	NeuroThera DE	Not applicable	Completed	Depression, Depressive Disorder, Depressive Disorder, Major	50	Peru	clinicaltrials.gov
April 17, 2025	NCT06932263	Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled...	AstraZeneca	Phase 2	Recruiting	Asthma	540	Argentina, Brazil, Chile, China, France, Greece, Hungary, India, Israel, Italy...	clinicaltrials.gov
April 13, 2025	NCT06925737	A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)	Merck Sharp & Dohme LLC	Phase 3	Recruiting	Prostate Cancer, Prostatic Neoplasms	1,440	Argentina, Australia, Austria, Brazil, Chile, China, Colombia, Czechia...	clinicaltrials.gov
March 14, 2025	NCT06878261	A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)	AstraZeneca	Phase 3	Recruiting	Chronic Obstructive Pulmonary Disease (COPD)	990	Argentina, Australia, Belgium, Bulgaria, Colombia, Denmark, France, Greece...	clinicaltrials.gov
March 4, 2025	NCT06857461	Effect of the Uriclarity Program on Perceived Milk Supply in Postpartum Women in Piura-Peru	Crianzamor	Not applicable	Completed	Perceived Insufficient Milk Supply	91	Peru	clinicaltrials.gov
February 24, 2025	NCT06841354	A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With...	Merck Sharp & Dohme LLC	Phase 3	Recruiting	Triple Negative Breast Neoplasms	1,000	Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Czechia...	clinicaltrials.gov
February 18, 2025	NCT06833073	A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)	Merck Sharp & Dohme LLC	Phase 2	Recruiting	Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ	308	Argentina, Australia, Brazil, Canada, Chile, Colombia, Denmark, France...	clinicaltrials.gov
February 13, 2025	NCT06824467	A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in...	Merck Sharp & Dohme LLC	Phase 3	Recruiting	Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer	770	Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia...	clinicaltrials.gov
February 6, 2025	NCT06812494	A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants...	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2	Active not recruiting	HIV	200	Brazil, Peru, United States	clinicaltrials.gov
January 15, 2025	NCT06777407	Brief Mindfulness-Based Intervention to Reduce Psychological Distress in Health Sciences Students	National University of San Marcos, Peru	Not applicable	Unknown	Mindfulness, Psychological Distress	120	Peru	clinicaltrials.gov
January 9, 2025	NCT06764875	A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for...	AstraZeneca	Phase 3	Recruiting	HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma	840	Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, France...	clinicaltrials.gov
December 27, 2024	NCT06751186	Effect of Teté Dance on Breastfeeding Duration in Irritable Infants	Crianzamor	Not applicable	Completed	Breastfeeding Duration, Infant Feeding Practices	150	Peru	clinicaltrials.gov
December 24, 2024	NCT06747949	A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)	Amgen	Phase 3	Recruiting	Sjögren's Syndrome	844	Argentina, Australia, Belgium, Brazil, Canada, Chile, Croatia, France, Germany...	clinicaltrials.gov
December 19, 2024	NCT06742723	A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With...	AstraZeneca	Phase 3	Recruiting	Chronic Kidney Disease and Hypertension	5,000	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
December 5, 2024	NCT06717347	A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP)...	Merck Sharp & Dohme LLC	Phase 3	Recruiting	Diffuse Large B-Cell Lymphoma	1,046	Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark...	clinicaltrials.gov
November 26, 2024	NCT06705478	Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in...	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2	Suspended	Major Depressive Disorder, Mild Neurocognitive Disorder, HIV	186	Botswana, Brazil, India, Kenya, Malawi, Mexico, Peru, Philippines, South...	clinicaltrials.gov
November 20, 2024	NCT06698042	A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer...	Merck Sharp & Dohme LLC	Phase 3	Active not recruiting	Lung Cancer, Non-Small Cell Lung Cancer	67	China, Germany, Guatemala, Japan, Peru, Poland, Romania, South Korea, Spain...	clinicaltrials.gov
November 18, 2024	NCT06692738	A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic...	AstraZeneca	Phase 3	Recruiting	Non-small Cell Lung Cancer	1,160	Argentina, Australia, Austria, Belgium, Brazil, Canada, China, France, Germany...	clinicaltrials.gov
November 12, 2024	NCT06684847	A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome	argenx	Phase 3	Active not recruiting	Primary Sjogrens Disease	631	Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Chile, China...	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
AstraZeneca	14	October 1, 2026
Merck Sharp & Dohme LLC	14	January 23, 2026
National Institute of Allergy and Infectious Diseases (NIAID)	7	September 14, 2026
Universidad Peruana Cayetano Heredia	3	September 10, 2026
Centre Paul Strauss	3	August 4, 2026
National University of San Marcos, Peru	2	March 17, 2026
Bristol-Myers Squibb	2	March 2, 2026
Immunovant Sciences GmbH	2	June 24, 2025
Crianzamor	2	March 4, 2025
Hospital Nacional Edgardo Rebagliati Martins	1	October 5, 2026
University of Notre Dame	1	June 25, 2026
HIV Prevention Trials Network	1	June 22, 2026
University of Wisconsin, Madison	1	June 18, 2026
Universidad Científica del Sur	1	June 15, 2026
Hospital Las Higueras	1	June 11, 2026
Universidad Nacional de San Agustin de Arequipa	1	May 28, 2026
Instituto Nacional Materno Perinatal, Peru	1	April 24, 2026
Oxford University Clinical Research Unit, Vietnam	1	April 21, 2026
R. Kiplin Guy	1	February 24, 2026
Contineum Therapeutics	1	December 16, 2025

Conditions

Condition group	New trials	Latest
Carcinoma, Non-Small-Cell Lung	6	January 23, 2026
Acquired Immunodeficiency Syndrome	4	June 22, 2026
Tuberculosis	3	September 14, 2026
Renal Insufficiency, Chronic	3	August 10, 2026
Gallbladder Neoplasms	3	August 4, 2026
Lupus Erythematosus, Systemic	3	June 5, 2026
Parkinson Disease 4, Autosomal Dominant Lewy Body	3	May 13, 2025
Fallopian Tube Neoplasms	2	October 1, 2026
Depression	2	June 25, 2026
Psychological Well-Being	2	June 25, 2026
HIV Infections	2	June 22, 2026
Acute Kidney Injury	2	June 11, 2026
Breast Feeding	2	March 17, 2026
Pulmonary Fibrosis	2	March 2, 2026
Idiopathic Pulmonary Fibrosis	2	March 2, 2026
Ovarian Neoplasms	2	January 6, 2026
Lung Neoplasms	2	August 17, 2025
Pulmonary Disease, Chronic Obstructive	2	July 24, 2025
Breast Neoplasms	2	July 11, 2025
Asthma	2	July 8, 2025
Hypertension	2	May 25, 2025
Triple Negative Breast Neoplasms	2	May 13, 2025
Prostatic Neoplasms	2	May 1, 2025
Depressive Disorder, Major	2	April 18, 2025
Urinary Incontinence	1	October 5, 2026

By phase

Phase	New trials	Latest
Phase 3	29	October 1, 2026
Not applicable	16	October 5, 2026
Phase 2	15	June 25, 2026
Observational	10	August 4, 2026
Phase 1	5	September 14, 2026
Phase 1/2	1	May 30, 2025

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.